Medicines Evaluation Board, Netherlands
Disclosure information not submitted.
6E-03 - A Target Trial Emulation with an Extension to Subgroups: an Example for Relapsing-Remitting Multiple Sclerosis
Tuesday, August 26, 20252:00 PM - 2:15 PM ET
